RXST - RxSight Inc
7.69
-0.120 -1.560%
Share volume: 779,364
Last Updated: 03-06-2026
Medical Equipment/Ophthalmic Goods:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$7.81
-0.12
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-05-2024 | 11-07-2024 | 02-25-2025 | 05-07-2025 | 11-05-2025 | 02-25-2026 | |
| Total revenue | 29.512 M | 34.887 M | 35.314 M | 40.214 M | 37.895 M | 30.340 M | 32.607 M | |
| Cost of revenue | 8.827 M | 10.637 M | 10.094 M | 11.426 M | 9.566 M | 6.113 M | 7.344 M | |
| Gross profit | 20.685 M | 24.250 M | 25.220 M | 28.788 M | 28.329 M | 24.227 M | 25.263 M | |
| 17.23% | 4.00% | 14.15% | -1.59% | -14.48% | 4.28% | |||
| Operating expenses | 31.355 M | 32.583 M | 34.446 M | 37.417 M | 39.003 M | 36.405 M | 36.599 M | |
| Selling general and admin | 23.324 M | 24.292 M | 25.608 M | 28.210 M | 28.636 M | 27.345 M | 27.694 M | |
| Research and development | 8.031 M | 8.291 M | 8.838 M | 9.207 M | 10.367 M | 9.060 M | 8.905 M | |
| Total expenses | 31.355 M | 32.583 M | 34.446 M | 37.417 M | 39.003 M | 36.405 M | 36.599 M | |
| 3.92% | 5.72% | 8.63% | 4.24% | -6.66% | 0.53% | |||
| Operating income | -10.670 M | -8.333 M | -9.226 M | -8.629 M | -10.674 M | -12.178 M | -11.336 M | |
| Ebit | -10.670 M | -8.333 M | -9.226 M | -8.629 M | -10.674 M | -12.178 M | -11.336 M | |
| Pretax income | -9.091 M | -6.063 M | -6.325 M | -5.926 M | -8.172 M | -9.806 M | -9.146 M | |
| -33.31% | 4.32% | -6.31% | 37.90% | 20.00% | -6.73% | |||
| Income tax | 9.000 K | 16.000 K | 13.000 K | 12.000 K | 18.000 K | 10.000 K | 6.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -9.100 M | -6.079 M | -6.338 M | -5.938 M | -8.190 M | -9.816 M | -9.152 M | |
| 33.20% | -4.26% | 6.31% | -37.93% | -19.85% | 6.76% |